BioSpace News Archive

Ontera, the leader in silicon-based nanopore diagnostics, today announced the appointments of Mark Rose as vice president of product management and Raparti Swayambhu as vice president of software.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from its prostate cancer and solid tumor portfolios will be featured at the European Society for Medical Oncology (ESMO) Annual Congress 2019, taking place September 27 to October 1 in Barcelona, Spain.

Washington University School of Medicine in St. Louis will use the uMR 570, enhanced with artificial intelligence, to advance the field of cardiovascular MR

Origin Agritech Ltd. (NASDAQ: SEED) (the “Company” or “Origin”), an agriculture technology and rural e-commerce company, today announced that the Company has entered into a collaboration agreement with Inova Genética Ltda (INOVA), a member of the Wehrmann Group, from Cristalina-GO, Brazil.

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research [17-September-2019] BALTIMORE , Sept. 17, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by H

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will provide a corporate overview at the Ladenburg Thalmann 2019 Healthcare Conference, to be held September 24, 2019 in New York City

Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings for medical devices, today announced that the company has launched an ISO-certified, full-service on-site facility for the application of its HYDAK® coatings to its customers unique medical devices

Sensorion has contributed two presentations in the scientific poster session at the 2019 Annual Meeting of the American Academy of Otolaryngology, Head and Neck Surgery/Foundation held in New Orleans LA, the 15-18th of September, 2019.

POXEL SA announced the initiation of a Phase 1b double-blind, randomized, placebo-controlled study in healthy subjects to evaluate the safety, tolerability and pharmacokinetics as well as support dose selection for a pivotal study of PXL065.

Sea turtles suffering from toxic red tide exposure could benefit from a therapy used to treat human drug overdoses.